BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 6363566)

  • 1. Deposition of the membrane attack complex of complement in bullous pemphigoid.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous pemphigoid autoantibodies reactive with intracellular basal keratinocyte antigens: studies of subclass distribution and complement activation.
    Jordon RE; Xia P; Geoghegan WD
    J Clin Immunol; 1992 May; 12(3):163-9. PubMed ID: 1400896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
    Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
    J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitronectin colocalizes with Ig deposits and C9 neoantigen in discoid lupus erythematosus and dermatitis herpetiformis, but not in bullous pemphigoid.
    Dahlbäck K; Löfberg H; Dahlbäck B
    Br J Dermatol; 1989 Jun; 120(6):725-33. PubMed ID: 2474318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of C3, C9 neoantigen and vitronectin (S-protein of complement) in lichen planus pemphigoides.
    Hintner H; Sepp N; Dahlbäck K; Dahlbäck B; Fritsch P; Breathnach SM
    Br J Dermatol; 1990 Jul; 123(1):39-47. PubMed ID: 1697188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
    Suzuki M; Watanabe C; Yaoita H
    Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence.
    Gammon WR; Robinson T; Briggaman RA; Wheeler CE
    J Invest Dermatol; 1982 Nov; 79(5):312-7. PubMed ID: 6752293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoelectronmicroscopic differentiation of linear IgA bullous dermatosis of adults with coexistence of IgA and IgG deposition from bullous pemphigoid.
    Adachi A; Tani M; Matsubayashi S; Shibata K; Horikawa T; Murata Y; Kumano K
    J Am Acad Dermatol; 1992 Sep; 27(3):394-9. PubMed ID: 1401273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cicatricial pemphigoid of Brunsting-Perry. Immunofluorescent studies.
    Michel B; Bean SF; Chorzelski T; Fedele CF
    Arch Dermatol; 1977 Oct; 113(10):1403-5. PubMed ID: 334084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes gestationis: fine structural pattern of immunoglobulin deposits in the skin in vivo.
    Hönigsmann H; Stingl G; Holubar K; Wolff K
    J Invest Dermatol; 1976 Jun; 66(6):389-92. PubMed ID: 778282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies.
    Gammon WR; Briggaman RA
    J Invest Dermatol; 1988 Apr; 90(4):495-500. PubMed ID: 3280699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
    Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclass distribution of IgG autoantibodies in bullous pemphigoid.
    Bird P; Friedmann PS; Ling N; Bird AG; Thompson RA
    J Invest Dermatol; 1986 Jan; 86(1):21-5. PubMed ID: 3528304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofluorescence studies of pemphigus and pemphigoid in Singapore.
    Tan T; Ratnam KV
    Ann Acad Med Singap; 1983 Jan; 12(1):13-8. PubMed ID: 6344738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation.
    Yamada H; Hashimoto T; Nishikawa T
    J Invest Dermatol; 1989 Apr; 92(4):585-7. PubMed ID: 2649595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathology of cicatricial pemphigoid: studies of complement deposition.
    Rogers RS; Perry HO; Bean SF; Jordon RE
    J Invest Dermatol; 1977 Jan; 68(1):39-43. PubMed ID: 318674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.